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Transmissible gastroenteritis virus (TGEV) isolates that have been adapted to passage in cell culture maintain their infectivity in vitro but may
lose their pathogenicity in vivo. To better understand the genomic mechanisms for viral attenuation, we sequenced the complete genomes of two
virulent TGEV strains and their attenuated counterparts: virulent TGEV Miller M6 and attenuated TGEV Miller M60 and virulent TGEV Purdue
and attenuated TGEV Purdue P115, together with the ISU-1 strain of porcine respiratory coronavirus (PRCV-ISU-1), a naturally occurring TGEV
deletion mutant with an altered respiratory tropism and reduced virulence. Pairwise comparison at both the nucleotide (nt) and amino acid (aa)
levels between virulent and attenuated TGEV strains identified a common change in nt 1753 of the spike gene, resulting in a serine to alanine
mutation at aa position 585 of the spike proteins of the attenuated TGEV strains. Alanine was also present in this protein in PRCV-ISU-1.
Particularly noteworthy, the serine to alanine mutation resides in the region of the major antigenic site A/B (aa 506–706) that elicits neutralizing
antibodies and within the domain mediating the cell surface receptor aminopeptidase N binding (aa 522–744). Comparison of the predicted
polypeptide products of ORF3b showed significant deletions in the naturally attenuated PRCV-ISU-1 and TGEV Miller M60; these deletions
occurred at a common break point, suggesting a related mechanism of recombination that may affect viral virulence or tropism. Sequence
comparisons at both genomic and protein levels indicated that PRCV-ISU-1 had a closer relationship with TGEV Miller strains than Purdue
strains. Phylogenetic analyses showed that virulence is an evolutionarily labile trait in TGEV and that TGEV strains as a group share a common
ancestor with PRCV.
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Transmissible gastroenteritis virus (TGEV) is a group 1
coronavirus. It was identified as an etiological agent of
transmissible gastroenteritis in swine in 1946 in the United
States (Doyle, 1951; Doyle and Hutchings, 1946) and in the⁎ Corresponding author. Fax: +1 330 263 3677.
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doi:10.1016/j.virol.2006.08.051following two decades after its discovery, it was reported in
England, Belgium, Japan, China, Australia and Africa (Kemeny
and Woods, 1977; Pritchard, 1987; Wood et al., 1981; Woods,
1976; Woods and Wesley, 1986). Transmissible gastroenteritis
virus replicates in the cytoplasm of villous epithelial cells in the
small intestine, leading to severe villous atrophy and malab-
sorptive diarrhea, resulting in almost 100% mortality in
seronegative suckling pigs (Saif and Sestak, 2006). The virus
is an enteropathogen, although TGEValso replicates in the upper
425X. Zhang et al. / Virology 358 (2007) 424–435respiratory tract (Underdahl et al., 1975) with transient nasal
shedding in experimentally inoculated pigs (VanCott et al.,
1993).
Transmissible gastroenteritis virus has a positive-sense,
single-stranded RNA genome of∼28.5 kb in size. The genomic
sequence contains 9 open-reading frames (ORFs) that encode 4
structural proteins [spike (S), envelope (E), membrane (M) and
nucleoprotein (N)] and 5 nonstructural proteins (replicase 1a
and 1b, 3a, 3b, and protein 7) arranged on the genome in the
order 5′-replicase (1a/1b)-S-3a-3b-E-M-N-7-3′. The S glyco-
protein of TGEV forms large, petal-shaped spikes on the surface
of the virion which are responsible for binding to specific
receptors on the membranes of susceptible cells. Aminopepti-
dase N (APN) is the major cell surface receptor for TGEV
(Delmas et al., 1992) and several co-receptors including
sialoglycoproteins have been implicated in conferring enteric
tropism to TGEV (Ballesteros et al., 1997; Delmas et al., 1993).
Four major antigenic sites, A, B, C and D were characterized on
the N terminus of the S protein using monoclonal antibodies
(Correa et al., 1988; Delmas et al., 1986, 1990; Simkins et al.,
1992). Monoclonal antibodies against S can neutralize virus
infectivity either by blocking virus attachment to cells or
through interfering with virus endocytosis or membrane fusion
(Sune et al., 1990). The adjacent sites A and B were mapped to a
region of approximately 200 amino acids beginning from
residue 506 as its N terminal boundary (Godet et al., 1994).
Antigenic sites A/B also overlap with the domain of the S
protein encompassing amino acids 522–744 that mediate
aminopeptidase N (APN) receptor binding (Godet et al.,
1994). Three antigenic sites were also defined in the N protein
(Martin Alonso et al., 1992; Simkins et al., 1989).
After continuous passage in cell culture, TGEV isolates
gradually lose their virulence and viral tropisms may shift from
enteric to respiratory (Furuuchi et al., 1978; Harada et al.,
1969). Attenuation and tropism shift can also occur in nature, an
example being the naturally occurring S gene deletion mutant,
the porcine respiratory coronavirus (PRCV), which has both
reduced pathogenicity and a predominantly respiratory tropism
(Pensaert et al., 1986; Saif and Sestak, 2006; Wesley et al.,
1990a,b). In contrast to TGEV, PRCV mainly infects the
respiratory tract, causing mild to moderate pneumonia often
with pronounced interstitial lung lesions, but with little or no
replication in the intestine. Studies of PRCV have provided
some insight into the determinants for the tropism and virulence
changes in TGEV. At the genome level, PRCVand TGEV share
high nucleotide sequence identity except that PRCV has a
deletion in the 5′ end of the S gene and deletions in ORF3, the
latter leading to lack of or a truncated protein expressed. The 5′
deletion in the S gene is widely believed to play a major role in
the altered tissue tropism of PRCV (Wesley et al., 1990a,
1990b, 1991). Ballesteros et al. (1997) and Sanchez et al.
(1999) identified two domains in the spike protein of
attenuated TGEV Purdue strain PUR46-MAD responsible for
binding APN and co-receptors and demonstrated that a
respiratory Purdue Type TGEV (PTV) (formerly known as
NEB72) lost the co-receptor binding site due to the S gene
mutation. Point mutations in the spike gene leading to a shiftfrom enteric to respiratory tropism were also found in high cell
culture passaged TGEV strain TOY56 (Sanchez et al., 1992).
Thus the spike protein has been recognized as not only a
tropism but also a virulence determinant.
Although it is generally accepted that deletions in the spike
and ORF3 genes contribute to tropism change and attenuation
of PRCV, other genes may also be involved. For instance, amino
acid mutations in the M protein affect the ability of attenuated
Purdue TGEV P115 to induce IFN-alpha, implying a potential
role for the M protein in altered host response and virulence
(Laude et al., 1992). Other evidence has implicated a role for
nonstructural proteins 3a and 3b in determining virulence of
these swine enteric and respiratory coronaviruses (Paul et al.,
1997). An infectious clone of TGEV Purdue strain PUR46-
MAD with ORF3 gene deletions showed a slightly reduced
pathogenicity in vivo, but normal replication in cell culture
(Sola et al., 2003). Similar effects of ORF3 deletion were also
observed for the group 3 coronavirus, infectious bronchitis virus
(Hodgson and Cavanagh, 2006; Shen et al., 2003). However, in
one study a TGEV strain 96–1933 with a deletion in ORF3a
was demonstrated to maintain enteric virulence (McGoldrick
et al., 1999), suggesting that ORF3a is not essential for
virulence, although the virulence of this virus needs to be
further confirmed because the virus isolated and sequenced
was not plaque purified and was not tested in pigs after plaque
purification.
To determine the molecular basis for TGEV attenuation,
we analyzed the nucleotide and deduced amino acid
sequences of structural and nonstructural proteins of two
virulent/attenuated TGEV pairs as well as the PRCV strain
ISU-1. Determining tropism and virulence factors at the
genomic level for TGEV/PRCV strains should enhance our
understanding of the evolution of coronaviruses including the
newly emerged severe acute respiratory syndrome corona-
virus (SARS-CoV) (Marra et al., 2003; Rota et al., 2003;
Saif, 2004, 2005).
Results
Assembly and validation of TGEV genomic sequences
Sequencing reads were downloaded, trimmed to remove
amplicon primer-linker sequences as well as low quality
sequence and assembled using TIGR Assembler (www.tigr.
org/software/assembler/). To close gaps between assembled
contigs, strain-specific primers were designed, RT-PCR was
performed and amplicons were sequenced as described in
Materials and methods. Additional primer design, cDNA
synthesis and sequencing were performed to ensure greater
than 4× sequence coverage along the coronavirus genomes.
Assemblies were manually edited using CloE (Closure Editor),
a TIGR program for editing assemblies. All apparent poly-
morphisms were checked against reference data and ambiguities
were analyzed by RT-PCR and cloning.
The final genome assemblies have been deposited in
GenBank. The GenBank accession numbers are as follows:
Virulent TGEVMiller M6:DQ811785; attenuated TGEVMiller
Table 2
Length in amino acids of predicted structural and nonstructural proteins of the
four TGEV isolates and PRCV-ISU-1
Virulent
TGEV
Miller M6
Attenuated
TGEV
Miller M60
Virulent
TGEV
Purdue
Attenuated
TGEV
Purdue P115
PRCV-
ISU-1
Replicase 1a 4017 4017 4017 4017 4014
Replicase 1b 2680 2680 2680 2680 2680
S 1449 1448 1449 1447 1222
3a 72 72 71 71 –
3b 244 67 244 244 205
E 82 82 82 82 82
M 262 264 262 262 261
N 382 382 382 382 382
7 78 78 78 78 78
426 X. Zhang et al. / Virology 358 (2007) 424–435M60: DQ811786; PRCV-ISU-1: DQ811787; attenuated TGEV
Purdue P115: DQ811788; virulent TGEV Purdue: DQ811789.
The genome lengths in nt for TGEV virulent Miller M6,
attenuated Miller M60, virulent Purdue, attenuated Purdue P115
and PRCV-ISU-1 are 28542, 27915, 28577, 28571, and 27546,
respectively.
Genetic characterization of the TGEV and PRCV genomes
Genome sequence alignment of the TGEV strains and PRCV
with the reference genome sequence of TGEV strain PUR46-
MAD from GenBank (accession number NC_002306) showed
comparable genome size and identical gene order. All 5
genomes start with 5′ untranslated regions similar to that of
the reference strain above and end with a polyA tail except that
the sequence for M60 is 69 nt short of reaching the polyA end.
The TGEV and PRCV strains share high genomic sequence
identities, ranging from 96.2% to 99.9% (Table 1). PUR46-
MAD and Purdue P115 showed 99.9% genomic sequence
similarity, because TGEV PUR46-MAD strain was derived
from TGEV Purdue P115 and similarly attenuated from the
virulent TGEV Purdue strain after high passage in cell culture
(Penzes et al., 2001; Sanchez et al., 1992).
The 5 genomes contained 8 to 9 open-reading frames (ORFs)
typical of other TGEV and PRCV strains. The length in amino
acids of the structural and nonstructural proteins of the four
TGEV strains and PRCV-ISU-1 is summarized in Table 2. No
protein 3a is encoded in PRCV-ISU-1 due to a 184 nt deletion at
the 5′ end of the 3a gene.
Nucleotide and amino acid changes in structural and
nonstructural proteins after attenuation
Each viral assembly was analyzed using Viral Genome ORF
Reader (VIGOR), a program designed at TIGR to predict viral
protein sequences. Using VIGOR, we checked segment length,
alignments with reference sequences, fidelity of reading frames,
correlated amino acid mutations with nucleotide polymorph-
isms and detected potential sequence errors. The open-reading
frames of the structural and nonstructural proteins of the four
TGEV strains were aligned using the ClustalW algorithm to
identify amino changes after attenuation. Comparison of
individual proteins from each of the TGEV isolates revealed a
number of deletions, insertions and point mutations that areTable 1
Pairwise distance of genomes of PRCV-ISU-1, the four TGEV strains and the refere
Reference
TGEVNC_002306
Attenuated TGEV
Miller M60
Reference TGEV-NC_002306 *** 98.7
Attenuated TGEV Miller M60 1.2 ***
Virulent TGEV Miller M6 1.2 0.1
Virulent TGEV Purdue 0.1 1.1
Attenuated TGEV Purdue P115 0.1 1.3
PRCV-ISU-1 2.5 2
a Pairwise distance was calculated with ClustalW program using DNASTAR softwa
divergency in lower portion of table.summarized in Table 3. A total of 20 amino acid point mutations
were found in Miller M60 and 32 point mutations were found in
Purdue P115, when compared to their virulent counterparts
(Table 3).
Spike gene
A schematic illustration of spike gene changes and deletions
in TGEV isolates and PRCV is presented in Fig. 1. The most
striking variation between attenuated and virulent isolates was
seen in the spike and ORF3a/3b genes. Large deletions were
present in the spike gene of PRCV-ISU-1 and in the ORF3 gene
of both PRCV-ISU-1 and M60 (Tables 3 and 4). A 3 nt deletion
was present in the S gene of Miller M60 from 2385–2387,
resulting in a spike protein of 1448 aa in length, 1 aa shorter
compared to Miller M6. In Purdue P115 there was a 6 nt
deletion in the S gene, leading to a spike protein 2 aa shorter
than virulent Purdue strain (1447 vs. 1449 aa). Sequence
analysis confirmed the previously reported 681 nt deletion in
the 5′ end of the S gene in PRCV-ISU-1 (Bae et al., 1991;
Wesley et al., 1991).
A common T (virulent TGEV strains) to G mutation for both
M60 and Purdue P115 was located at nt 1753 of the spike
genes. The PRCV-ISU-1 strain had a G at the corresponding
nucleotide position. This mutation that resulted in a serine to
alanine mutation at aa 585 of the spike protein, was the only
common amino acid change found between both the Miller and
Purdue strains after attenuation. Because the alanine residue
was also observed at the corresponding position (585) in thence TGEV PUR46-MAD strain (GenBank Accession number NC_002306) a
Virulent TGEV
Miller M6
Virulent TGEV
Purdue
Attenuated TGEV
Purdue P115
PRCV-ISU-1
98.8 99.8 99.9 97.5
99.9 98.8 98.7 96.2
*** 98.9 98.7 98
1.1 *** 99.8 97.6
1.2 0.2 *** 97.5
2 2.4 2.6 ***
re. Percent similarity in upper right portion of table (above asterisks) and percent
Table 3
Amino acid mutations in the structural and nonstructural proteins of M60 and
P115 relative to their virulent counterparts a
aa
Position b
M6 c M60c Virulent
Purduec
P115c
Replicase 1a 572 S S S F
724 S S S G
799 V V V I
984 N T N N
1174 E A E E
1541 V V V I
1576 S S S G
1579 I I I V
1884 Q H Q Q
2732 T T T I
2816 P P P S
2818 D D D A
3366 V V V I
3786 A A A S
3883 A A A S
4015 P Q Q Q
No. of mutations 4 12
Replicase 1b 120 A A V A
1250 N D N N
2520 C G G G
No. of mutations 2 1
Spike 32 H H H Q
53 V A V V
86 L L L V
97 L S W W
99 H Y H H
208 L L L F
318 L F F F
375 N N Y Deleted
376 D D D Deleted
403 L L L H
417 P P P L
418 S I S S
496 L L L I
536 G G D G
562 N N N H
564 T N T T
585 d S A S A
675 L L L V
796 V Deleted V V
884 L Q Q Q
942 E E G E
1109 T T T I
1234 A A A P
No. of mutations 8 13
Protein 3a 8 N N D Y
29 V I V V
72 H H Deleted Deleted
No. of mutations 1 1
Protein 3b 8 N N N S
32 Q H Q Q
33–209 Deleted
No. of mutations 1 1
E 13 N T N N
18 S S S N
33 L S S S
No. of mutations 2 1
M 67–68 Insertion
156 N N N K
No. of mutations 0 4
N 110 D D E D
182 S S F S
(continued on next page)
Table 3 (continued)
aa
Position b
M6 c M60c Virulent
Purduec
P115c
N 287 I V I I
No. of mutations 1 2
Protein 7 71 Y F Y Y
No. of mutations 1 0
a Deduced protein sequences of all four TGEV viruses were aligned with
ClustalW program in Lasergene software (DNASTAR Inc.).
b Positions for amino acid changes are shown.
c Amino acids are bold italics when mutations are present between virulent
and attenuated TGEV strains.
d The common mutation between the two virulent and attenuated pairs at aa
585 in spike protein is highlighted by underlining.
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of attenuation among TGEV and PRCV strains but further
analysis using reverse genetics and experimental animal studies
is needed to confirm this possibility.
ORF3a/3b gene
The ORF3a/3b deletions are represented schematically in
Fig. 2a. PRCV-ISU-1 showed a 184 nt deletion in the
ORF3a gene, disrupting the predicted open-reading frame of
nonstructural protein 3a. A 3 nt deletion upstream and a 5 nt
deletion downstream of the 184 nt deletion were also found.
Furthermore, PRCV-ISU-1 contained a 117 nt in frame
deletion in ORF3b gene, leading to a shorter nonstructural
protein 3b relative to TGEV strains. Sequence comparison of
ORF3 genes between the Miller and Purdue strains revealed
2 large deletions (16 and 29 nt respectively) in the ORF3a
gene of the Miller strains. A previously undescribed 29 nt
deletion was also present in PRCV-ISU-1 at exactly the same
position as Miller strains when compared to Purdue strains.
Miller M60 had a 531 nt in frame deletion in ORF3b gene
resulting in a truncated 3b protein of 67 aa long. The
deletion in M60 ORF3b gene was noted previously by our
laboratory (Kwon et al., 1998) and was independently
confirmed in this study by RT-PCR and sequence analysis
(data not shown). Interestingly, these deletions occur at the
same amino acid position (aa 33) in the predicted poly-
peptides of M60 and PRCV-ISU-1 (Fig. 2b); the apparent
recombination point in the nucleotide sequence occurs
within 2 nucleotides of each other as determined by
ClustalW alignment (Fig. 2c).
3′ end genes
Analysis of the 3′ end of the viral genomes revealed four
genes encoding E, M, N, and protein 7. No deletions or
insertions were present in E, N, and protein 7 genes. The
deduced E and N proteins and protein 7 among the 5 viruses
were 82 aa, 382 aa and 78 aa, respectively. There was a small
variation in M protein size with M60 having a 6 nt insertion in
the M gene when compared to the other 3 TGEV strains, leading
to a membrane protein 2 aa longer than those of M6 and Purdue
Fig. 1. Schematic representation of the spike gene of the four TGEV strains and PRCV-ISU-1 showing deletions and mutations.△, 3 nt (nt 2385 to 2387) deletion in
M60 spike gene and 6 nt (nt 1122 to 1127) deletion in P115 spike gene. , 681 nt (nt 65 to 745) deletion in PRCV spike gene. The T to G (bold) mutation at nt 1753
in M60, P115 and PRCV leading to an S to A substitution at aa 585 in the spike protein is shown. The approximate antigenic region of site A/B (nt 1518–2118) and the
aminopeptidase N (APN) binding site (nt 1566–2232) are indicated. The potential enteric tropism determining residue at nt position 655 identified by Ballesteros et. al.
(1997) is shown.
428 X. Zhang et al. / Virology 358 (2007) 424–435strains (264 aa and 262 aa respectively). The PRCV-ISU-1 had a
3 nt deletion in the M gene, resulting in an M protein of 261 aa.
Replicase 1a and 1b
About two thirds of the TGEV genome encodes the replicase
genes 1a and 1b. The replicase genes are relatively conserved
and no major deletions and insertions were present. In both the
Miller and Purdue isolates, the replicase 1a gene was predicted
to encode a protein of 4017 aa and the replicase 1b gene was
predicted to encode a protein of 2680 aa. Comparison of the
predicted polypeptide sequences indicated 4 aa changes in
replicase 1a and 2 aa changes in replicase 1b for the M6/M60
pair. Twelve aa changes in replicase 1a and 1 aa change in
replicase 1b were identified for virulent Purdue/P115 pair
(Table 3). However, no common changes were found between
the two pairs after attenuation.
Sequence differences between TGEV Miller and Purdue strains
and their relationship to PRCV-ISU-1
Two short deletions were seen in the replicase 1a gene of
PRCV-ISU-1, 6 nt from nt 3252 to 3257 and 3 nt from nt 3331
to 3333, respectively when compared to Miller and Purdue
strains. More sequence differences were found between PRCV-
ISU-1 and TGEV strains than between TGEV Miller and
Purdue strains. TGEV virulent Miller M6 shared 98.9%
genomic sequence identity with virulent Purdue strain.
PRCV-ISU-1 had 98.0% and 97.6% genomic sequence
identities with M6 and virulent Purdue, respectively. The
high sequence homology among TGEV strains and PRCV-ISU-1 suggests these viruses are closely related, but PRCV-
ISU-1 has a closer relationship with TGEV Miller strains than
Purdue strains. To identify differences at the aa level,
individual proteins of Miller and Purdue strains were
compared. Amino acids of PRCV-ISU-1 at divergent positions
were also listed (Table 4). Proteins of PRCV-ISU-1 were more
biased toward Miller strains than Purdue strains, including S,
protein 3a/3b, E, M, N and protein 7.
Phylogenetic analysis of TGEV and PRCV-ISU-1 genomic
sequences
Sequence comparisons at both genomic and protein levels
indicated that PRCV-ISU-1 had a closer relationship with
TGEV Miller strains than Purdue strains. To further define the
ancestry relatedness of PRCV-ISU-1 to TGEV stains, phylo-
genetic analysis of PRCV-ISU-1 was performed against the 4
TGEV strains and PUR46-MAD genomic sequence available
in GenBank (accession number NC_002306). The phyloge-
netic tree was rooted with a feline coronavirus (accession
number NC 007025) as an outgroup. The tree showed that
Miller M6 and Miller M60 were most closely related with each
other, consistent with the fact that both M6 and M60 are
derived from Miller strain (Fig. 3). Purdue P115 clustered most
closely with PUR46-MAD and together these two Purdue
strains shared the closest relationship with virulent Purdue.
PUR46-MAD strain is a derivative of the TGEV Purdue-P115
strain and both strains were derived from the virulent Purdue
strain (Penzes et al., 2001; Sanchez et al., 1999). The tree also
revealed that all TGEV strains were clustered into one clade,
indicating TGEV strains share a common ancestor and as a
Table 4
Amino acid differences in the structural and nonstructural proteins of TGEV
Miller and Purdue strains a
aa
Position b
M6 M60 Virulent
Purdue
P115 PRCV-ISU-1 c
Replicase 1a 102 F F L L F
286 T T A A A
343 I I V V I
355 E E D D E
521 A A V V A
590 M M V V V
639 L L F F L
803 E E K K E
821 A A S S A
888 D D E E D
1008 N N D D N
1023 I I T T I
1029 A A V V A
1035 V V A A A
1079 T T N N N
1299 L L P P L
1708 R R K K K
1800 R R K K K
1894 V V A A A
2178 N N S S N
2267 L L F F F
2420 A A V V V
2741 V V I I I
2763 V V I I V
3232 F F V V F
4000 S S F F S
Replicase 1b 272 H H Y Y Y
459 H H Q Q Q
480 S S N N S
718 V V I I V
1290 V V A A V
1479 S S A A A
1957 T T M M M
2081 R R K K R
2123 N N K K N
Spike 48 S S P P
72 N N D D
100 K K R R AA 23–250
184 A A E E Deleted
218 T T V V
384 S S F F S
389 M M I I I
487 Y Y H H Y
590 V V I I V
649 D D E E D
815 L L F F L
951 D D H H D
967 A A D D S
1239 L L S S L
Protein 3a 50 R R K K No protein
3A due to
deletion in
3A gene
67 T T S S
68 Q Q H H
69 N N I I
70 P P V V
71 K K V V
Protein 3b 31 K K Q Q Q
239 R R H H R
E 58 V V A A V
82 V V A A V
M 24 D D S S Deleted
27 G G D D G
64 I I V V I
(continued on next page)
Table 4 (continued)
aa
Position b
M6 M60 Virulent
Purdue
P115 PRCV-ISU-1 c
M 96 I I V V I
N 28 S S N N S
262 S S T T S
320 E E G G E
355 E E D D E
376 M M I I M
Protein 7 4 L L F F L
14 T T I I T
39 D D N N D
60 L L V V L
76 I I T T I
a Deduced protein sequences of all four TGEVs and PRCV-ISU-1 were
aligned with ClustalW program in Lasergene software (DNASTAR Inc.).
b Positions at which amino acid is different were listed.
c The aa of PRCV-ISU-1 at the divergent positions is listed. Letters are in bold
when PRCV-ISU-1 has identical aa as Miller strains at the divergent positions.
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ISU-1 (Fig. 3).
Discussion
We completed the entire genomic sequences of two virulent/
attenuated TGEV pairs and the ISU-1 strain of PRCV. Although
partial sequences of these strains were available in GenBank, to
our knowledge this is the first report of the full genomic
sequence of these pairs of viruses in comparison to one another
and to a PRCV strain. The detailed comparison of the sequences
of the 2 virulent and attenuated TGEV pairs aids in the
identification of the genetic basis of coronavirus attenuation,
which has not yet been clearly established and provides targets
for verification of the role of such changes using infectious
clones of TGEV. Sequences for TGEV genomes in public
databases are lacking; before the present study there were only
three complete genomic sequences of any TGEV strains in
GenBank (accession number NC_002306, DQ443743 and
DQ201447). Addition of the full genomic sequences for these
5 viruses will aid in understanding animal coronaviruses
including their genetic structure, diversity and evolution.
The sequence analyses identified deletions that were
reported previously including the 6 nt deletion in the S gene
of the Purdue P115 compared to the virulent Purdue strain
(Rasschaert and Laude, 1987) and 2 large deletions (16 and 29
nt respectively) in the ORF3a gene of the Miller strains when
compared to the Purdue strains (Rasschaert et al., 1987; Wesley
et al., 1989). Alignment of the genome sequences of the two
virulent/attenuated pairs of TGEV strains revealed a common
change at nt 1753 of the spike gene, resulting in a serine to
alanine mutation in aa position 585 of the spike protein of the
attenuated strains. This was the only common change at the
protein level found in the attenuated viruses in comparison to
their virulent counterparts. Interestingly, the naturally attenuated
PRCV-ISU-1 also has an alanine residue at the corresponding
position. This suggests that the alanine in place of serine may be
a genetic marker for attenuation of TGEV strains and for PRCV
Fig. 2. (a) Schematic representation of ORF3a/3b gene (nt 1 to 1043) and the 100 nt preceding the gene (nt −100 to 0): Gene start codon ATG for nonstructural protein
3a starts from nt 1 and ends at nt 247 for M6 and M60 and nt 215 for virulent Purdue and Purdue P115. No nonstructural protein 3a is encoded for PRCV-ISU-1 due to
the 184 nt deletion that includes the ATG start codon. Nonstructural protein 3b starts from nt 310 and ends at nt 1043.△, 3 nt (nt −100 to −98) deletion at 5′ end and
5 nt (nt 163 to 167) deletion downstream in ORF3a of PRCV-ISU-1. In TGEV M6 and M60,△ represents 16 nt (nt −76 to −61) deletions. □, 29 nt (nt 195 to 223)
deletion in PRCV, M6 andM60. , 531 nt (nt 405 to 935) deletion in M60 3b and 184 nt (nt −87 to 97) and 117 nt (nt 407 to 523) deletions in PRCV 3b respectively.
(b) ClustalW alignment of ORF3b predicted polypeptides of TGEV strains and PRCV-ISU-1 showing the deletion start point in Miller M60 and PRCV. (c) ClustalW
alignment of the nucleotide sequence of TGEV strains and PRCV-ISU-1 in the region of ORF3b deletion start point.
430 X. Zhang et al. / Virology 358 (2007) 424–435which is also attenuated for pigs. A study by Sanchez et al.
(1992) revealed that all TGEV strains analyzed had an alanine at
aa 585 of the spike protein except for Mil65-AME. The MIL65-Fig. 3. Phylogenetic analysis of genomic nucleotide sequences of the four TGEV stra
and a Feline Coronavirus outgroup. The tree is based on muscle alignment of whole
equally weighted parsimony counting gaps as a fifth state. Tree search was conducted
search procedure produced a single tree of 7360 steps. Bootstrap values for 1000 reAME strain so designated by Enjuanes and colleagues is a
derivative of our virulent Miller strain as demonstrated (Penzes
et al., 2001). It was the only virulent enteric TGEV strainins and PRCV-ISU-1 with the reference TGEV genomes available in GenBank,
genomes. The tree search was conduced with TNT (Goloboff et al., 2005) with
using new technology parameters until a stable consensus was discovered. This
sampling replicates are shown at nodes.
431X. Zhang et al. / Virology 358 (2007) 424–435analyzed in their study and the other strains were either
respiratory or attenuated by high passage through tissue culture.
A phenotypic change in TGEVresulting from a similar single
nucleotide change at a different site in the spike protein has been
reported previously. In a prior study, Ballesteros et al. (1997) and
Sanchez et al. (1999) identified a G residue at nt position 655 of
the spike protein that was essential to maintain enteric tropism of
TGEV strain PUR46-MAD. Mutations at this nucleotide caused
a shift from enteric to respiratory tropism of this virus. The 6 nt
(nt 1122 to 1127, aa 375–376) deletion in the attenuated TGEV
Purdue P115 spike gene, but not in the virulent Purdue strain,
that we observedmay also play a role in its attenuation. Penzes et
al. (2001) observed the same deletion in the spike gene of
attenuated Purdue strains PUR46-C8 and PUR46-MAD, but not
in the in vivo maintained virulent strain PUR46-C11.
The serine to alanine mutation at aa 585 is located in the
major antigenic sites A/B of TGEV spike proteins and within
the binding site for receptor APN (Delmas et al., 1986, 1990),
suggesting that this change may have a significant influence in
the receptor binding or neutralizing antibody interactions.
Single amino acid changes in the spike protein of coronaviruses
can have significant effects on antigenicity. For example, a
single amino acid change in the antigenic domain II of the spike
protein confers resistance to neutralization of a bovine
coronavirus (Yoo and Deregt, 2001). The alanine residue is
also present at the corresponding position in the spike protein of
PRCV-ISU-1. Antigenic site A/B has been mapped from aa 506
to 706 of the spike protein (Godet et al., 1994); within this
region there were 2 aa changes for M60 as compared to M6 and
4 aa changes for Purdue P115 as compared to virulent Purdue.
However, the impact of the serine to alanine mutation on pig
pathogenicity awaits generation of recombinant viruses by
reverse genetics followed by their testing in vivo.
Although researchers have indicated that deletions in ORF3
may be involved in the virulence of TGEV (Paul et al., 1997)
and deletion of ORF3 gene in a recombinant TGEV virus
showed a limited effect on the viral virulence in vivo (Sola et al.,
2003), only one mutation, but no deletions and insertions was
found in the ORF3a and ORF3b proteins of the attenuated
Purdue TGEV P115 when compared to the virulent Purdue
TGEV and no mutations in ORF3 proteins were shared in the
two virulent/attenuated pairs. It is noteworthy that we predicted
the existence of protein 3b of virulent and attenuated Purdue
TGEV viruses using the VIGOR program. Others suggested
that the mRNA encoding protein 3b was not observed in TGEV
Purdue, but only in Miller strains using infected cell lysates and
Northern blot analysis (Izeta et al., 1999; Penzes et al., 2001)
and therefore described it as a pseudogene in TGEV Purdue
strains. A mutation was found in the highly conserved core
sequence (CS, previously known as intergenic sequence IS)
within coronavirus transcription regulatorymotif, 5′-CUAAAC-
3′, preceding ORF3b genes of the TGEV Purdue strains. This
mutation replaced the last nucleotide C in CS with U. Because
the CS represents signals for coronavirus transcription of
subgenomic mRNAs (Lai and Cavanagh, 1997; Sawicki and
Sawicki, 1990), it is speculated that the mutation renders the
mRNA encoding the 3b protein undetectable by Northern blotfor TGEV Purdue strains. However, the single mutation in the
CS preceding the ORF3b gene of TGEV Purdue viruses may
not completely abolish its transcription. It has been demon-
strated that a core sequence differing at the last nucleotide from
the canonical one (5′-CUAAAC-3′) maintains efficient tran-
scription for the downstream gene (Sola et al., 2003). Because
we observed this mutation in the CS of ORF3b gene for both
virulent Purdue and attenuated Purdue P115 strains, protein 3b
is unlikely to play a role in the attenuation of TGEV Purdue
strains. Similarly, the absence of mutations or deletions in the
nonstructural protein 7 of the virulent/attenuated Purdue TGEV
pair indicates that changes in this protein alone are unlikely to
be involved in the attenuation process, although evidence
suggests that deletion of the entire ORF7 gene resulted in
altered in vivo replication and virulence of TGEV based on a
recombinant PUR46-MAD virus (Ortego et al., 2003).
Due to lack of proof-reading activity of the virally encoded
RNA-dependent RNA polymerase, coronaviruses introduce
frequent mutations into their genomes during replication. In
addition to randomly generated mutations, RNA recombination
can also occur when multiple distinct coronavirus species infect
the same host. The occurrence of frequent genomic changes
leads to generation of new coronaviruses that can have altered
pathogenicity, different tissue tropism or ability to cross host
species barrier. An example is the SARS outbreak caused by a
previously unidentified coronavirus (SARS-CoV). Recent
studies identified bats as the likely natural reservoir of SARS-
CoV. The SARS-CoV-like coronaviruses of bats may have
potentially become adapted to humans through genomic
mutation and recombination events either directly or via
intermediate hosts (civet cats, etc.) (Hampton, 2005; Lau et
al., 2005; Li et al., 2005; Normile, 2005). Although occurrence
of SARS surprised the medical community, the relevance of
RNA recombination and mutation to animal coronavirus
evolution and tropism shift had been previously well recognized
for TGEVand PRCV strains (Saif, 2004, 2005; Saif and Sestak,
2006; Sanchez et al., 1992). The independent appearance of
PRCV in both Europe and the United States in the 1989s
highlighted the possible emergence of new coronavirus strains
with altered tissue tropism, virulence or host specificity due to
genomic deletion and mutation events. The European PRCV
strains characterized had a 672 nt deletion in the same position
within the S gene, suggesting they evolved from the same
predecessor (Callebaut et al., 1988; Sanchez et al., 1990, 1992).
However, the initial PRCV strains detected in the United States
had deletions of 681 nt in size (Kwon et al., 1998; Wesley et al.,
1991). Subsequently other PRCV strains were isolated that
varied in the size of the spike gene deletion (Halbur et al., 1993;
Kim et al., 2000; Vaughn et al., 1994). Nevertheless, deletions
in the S genes disrupt expression of antigenic sites on S proteins
of both European and American PRCV strains. As a result,
TGEV and PRCV can be serologically differentiated by
monoclonal antibodies to the two antigenic sites (Callebaut et
al., 1988; Simkins et al., 1993). TGEV and PRCV can also be
genetically differentiated by nested RT-PCR using primers
flanking the S gene deletion (Kim et al., 2000; Paton et al.,
1997).
432 X. Zhang et al. / Virology 358 (2007) 424–435Phylogenetic analysis revealed a close genetic relationship
between the PRCV-ISU-1 and the four TGEV strains, indicating
that PRCV-ISU-1 shares a common ancestor with TGEVMiller
and Purdue strains. Nevertheless, it remains unclear which
strain of TGEV is the immediate ancestor of PRCV-ISU-1. It
had been hypothesized that PRCV may have evolved from a
live vaccine strain of TGEV such as the Purdue strain used for
commercial vaccines in the US. However, our analysis suggests
that PRCV-ISU-1 may have evolved from a TGEV Miller-like
strain. Several lines of evidence support this conclusion. First,
our results showed that PRCV-ISU-1 has a higher genomic
sequence identity (98%) with Miller M6 than with Purdue
strains and it has a closer relationship to Miller strains than to
Purdue strains (including the complete Purdue strain genome
available in GenBank) by phylogenetic analysis. Secondly,
Miller strains have identical or similar deletions in the ORF3
gene as PRCV-ISU-1. The 29 nt deletion from nt 195 to 223 of
the ORF3 gene of PRCV-ISU-1 is shared by Miller strains, but
not by Purdue strains. The 117 nt deletion in ORF3b gene (nt
407 to 523) of PRCV-ISU-1 overlaps with the 531 nt deletion in
ORF3b of Miller M60. This deletion is notable because it occurs
at the same amino acid in each predicted polypeptide and at
equivalent nucleotide coordinates in both M60 and PRCV-ISU-
1. The fact that PRCV-ISU-1 has the closest relationship with
Miller strains at both the genomic and protein levels and the
ORF3 gene of Miller strains also have a high frequency of
mutations and deletions suggests that a Miller-like strain is the
ancestor of PRCV-ISU-1 and M60 may represent an analog of
an intermediate species during PRCV evolution from a TGEV
Miller-like strain.
Our sequence analysis revealed that genetic divergence most
frequently occurs within the S gene and also between the S and
M genes of TGEV in ORF3a/3b, suggesting that these regions
are under the highest selective pressure during TGEVevolution.
Mutations and deletions in these regions have been documented
in TGEV variants that have altered tropisms, virulence or
phenotype (Kim et al., 2000; Kwon et al., 1998; Page et al.,
1991; Sanchez et al., 1992; Wesley et al., 1990a, 1990b, 1991).
Our sequence analyses of the 4 TGEV strains and PRCV-ISU-1
have identified two common changes in the variable S and
ORF3 genes, the T to G mutation at nt 1753 of the S genes of
the attenuated M60 and P115 compared to the virulent
counterparts and the deletions in ORF3b genes of M60 and
PRCV-ISU-1 starting at a nearly identical position for each.
These deletions may also be related to common mechanisms of
attenuation between these related strains. We could not ascertain
whether genetic changes at these two positions alone may have
altered viral virulence; however, identification of these two
common changes should help to localize sequences determining
TGEV attenuation as confirmed by using reverse genetics.
Materials and methods
Viruses
The history of prototypic virulent TGEV Miller M6,
attenuated TGEV Miller M60, virulent TGEV Purdue, attenu-ated TGEV Purdue P115, and PRCV-ISU-1 was summarized
previously (Simkins et al., 1992). Briefly M6 and M60 are low
and high tissue culture-passaged TGEV virulent and attenuated
Miller strains, respectively (Saif and Sestak, 2006). The virulent
Miller M6 was derived from field Miller isolate after 6 passages
and 2 plaque purification steps in swine testicular (ST) cells in
Ohio in 1965 (Bohl and Kumagai, 1965; Saif and Sestak, 2006;
Welch and Saif, 1988). The Miller M60 was attenuated after 60
passages and 2 plaque purification steps in ST cells (Saif and
Sestak, 2006; Woods, 1979). The virulent Purdue strain was
originally isolated by Haelterman in Indiana and passed 8 times
in pigs, with 2 subsequent cloning steps in ST cells (Haelter-
man, 1964). Continuous passage 115 times (115X), with
numerous plaque purifications of the virulent Purdue strain led
to the attenuated Purdue P115 strain (Bohl et al., 1972). The
ISU-1 strain of PRCVoriginated from a herd isolate by Hill in
Indiana in 1990. It was passaged 8× in ST cell culture and
plaque purified 2× (Hill et al., 1990). The prototypic viruses
were subjected to additional passages in ST cells or gnotobiotic
pigs before sequencing in our lab. An additional 10, 4, 10, and
11 passages in ST cells were applied to Miller M6, Miller M60,
PRCV-ISU-1, and Purdue P115, respectively. For virulent
TGEV Purdue, 2 more passages were done in gnotobiotic pigs
and the cell passaged M6 (10 additional passages) was also
confirmed as virulent for the gnotobiotic pigs (Welch and Saif,
1988).
Virus purification and RNA extraction
Viral RNA was extracted from ST cell culture homogenates
(TGEV M6, M60, P115 and PRCV-ISU-1) or infected
gnotobiotic pig intestinal contents (virulent TGEV Purdue
virus) after sucrose gradient purification as previously described
(Kim et al., 2000; Paton et al., 1997). The total RNA was
extracted from viral cell culture supernatants using TRIZOL LS
reagent (Gibco, Life Tech, Grand Island, NY) according to the
manufacturer's instructions. For virulent TGEV Purdue, the
virus-containing gnotobiotic pig intestinal contents were
purified by ultracentrifugation (112,700×g for 18 h) on 20%
to 50% sucrose density gradients as described previously
(Hasoksuz et al., 2002).
Viral genome sequencing
Specific oligonucleotide primers were designed using atten-
uated TGEV strain PUR46-MAD (NC_002306) as a reference
genome. Primers were designed at every 500 bp along the
genome. An M13 sequence tag was added to the 5′ end of each
primer to be used for sequencing (forward primer: TGTAAAAC-
GACGGCCAGT; reverse primer: CAGGAAACAGCTAT-
GACC). Oligonucleotide primers were purchased from
Invitrogen (Carlsbad, California, USA). Primer sequences are
included in Supplementary Table S1. Reverse transcription and
polymerase chain reactions (RT-PCR) were performed with 50–
200 ng of coronavirus RNA supplemented with ribonuclease
inhibitor (RNASEOUT, Invitrogen, Carlsbad, California,
USA) using OneStep RT-PCR according to the manufacturers
433X. Zhang et al. / Virology 358 (2007) 424–435instructions (OneStep RT-PCR Kit, Qiagen, Valencia, CA,
USA). Duplicate reactions were analyzed for quality control
purposes by agarose gel electrophoresis. Amplicons were
prepared for sequencing by incubation at 37 °C for 60 min
with 0.5 U of Shrimp Alkaline Phosphatase (USB, Cleveland,
Ohio) and 1 U of Exonuclease I (USB, Cleveland, Ohio) to
inactivate remaining dNTPs and to digest the single-stranded
primers. The enzymes were inactivated by incubation at 72 °C
for 15 min. Sequencing reactions were performed on a
standard high-throughput sequencing system using Big Dye
Terminator chemistry (Applied Biosystems) with 2 μl of
template cDNA. Each amplicon was sequenced from each end
using M13 forward and reverse primers listed above.
Sequencing reactions were analyzed on a 3730 ABI sequencer.
Sequence alignment and phylogenetic analyses
Alignment of nucleotide and amino acid sequences was
performed using ClustalW program in Lasergene Software
(DNASTAR Inc. Madison, WI). The phylogenetic tree (Fig. 3)
was based on the entire genome alignment using multiple
sequence comparison by log-expectation (MUSCLE) software
(http://www.drive5.com/muscle/). The tree search was con-
ducted with equally weighted parsimony method with gaps
treated as a fifth state as implemented in TNT (Goloboff et al.,
2005). Tree search was conducted using new technology
parameters until a stable consensus was discovered. This search
procedure produced a single tree of 7360 steps. Bootstrap
values were calculated for 1000 resampling replicates.
Acknowledgments
This work was supported by grants R01 AI060739 and R21
AI062763 from the NIAID, NIH. Salaries and research support
were provided by state and federal funds provided to the Ohio
Agricultural Research and Development Center, The Ohio State
University. For the contributions of Daniel Janies, the support of
the Department of Biomedical Informatics and the Ohio State
University Medical Center and the support by, or in part by, the
U.S. Army Research Laboratory and the U.S. Army Research
Office under contract/grant number W911NF-05-1-0271 is
acknowledged.
Appendix A. Supplementary data
Supplementary data associated with this article can be found,
in the online version, at doi:10.1016/j.virol.2006.08.051.
References
Bae, I., Jackwood, D.J., Benfield, D.A., Saif, L.J., Wesley, R.D., Hill, H., 1991.
Differentiation of transmissible gastroenteritis virus from porcine respiratory
coronavirus and other antigenically related coronaviruses by using cDNA
probes specific for the 5′ region of the S glycoprotein gene. J. Clin.
Microbiol. 29 (1), 215–218.
Ballesteros, M.L., Sanchez, C.M., Enjuanes, L., 1997. Two amino acid changes
at the N-terminus of transmissible gastroenteritis coronavirus spike protein
result in the loss of enteric tropism. Virology 227 (2), 378–388.Bohl, E.H., Kumagai, T., 1965. The use of cell culture for the study of TGE virus
of swine. Proc. U. S. Livestock San Assoc. 69, 343–350.
Bohl, E.H., Gupta, R.K., Olquin, M.V., Saif, L.J., 1972. Antibody responses in
serum, colostrum, and milk of swine after infection or vaccination with
transmissible gastroenteritis virus. Infect. Immun. 6 (3), 289–301.
Callebaut, P., Correa, I., Pensaert, M., Jimenez, G., Enjuanes, L., 1988.
Antigenic differentiation between transmissible gastroenteritis virus of
swine and a related porcine respiratory coronavirus. J. Gen. Virol. 69,
1725–1730.
Correa, I., Jimenez, G., Sune, C., Bullido, M.J., Enjuanes, L., 1988. Antigenic
structure of the E2 glycoprotein from transmissible gastroenteritis
coronavirus. Virus Res. 10 (1), 77–93.
Delmas, B., Gelfi, J., Laude, H., 1986. Antigenic structure of transmissible
gastroenteritis virus: II. Domains in the peplomer glycoprotein. J. Gen.
Virol. 67, 1405–1418.
Delmas, B., Rasschaert, D., Godet, M., Gelfi, J., Laude, H., 1990. Four major
antigenic sites of the coronavirus transmissible gastroenteritis virus are
located on the amino-terminal half of spike glycoprotein S. J. Gen. Virol. 71,
1313–1323.
Delmas, B., Gelfi, J., L'Haridon, R., Vogel, L.K., Sjostrom, H., Noren, O.,
Laude, H., 1992. Aminopeptidase N is a major receptor for the entero-
pathogenic coronavirus TGEV. Nature 357 (6377), 417–420.
Delmas, B., Gelfi, J., Sjostrom, H., Noren, O., Laude, H., 1993. Further
characterization of aminopeptidase-N as a receptor for coronaviruses. Adv.
Exp. Med. Biol. 342, 293–298.
Doyle, L.P., 1951. Transmissible gastroenteritis of pigs. North Am. Vet. 32 (7),
477–478.
Doyle, L.P., Hutchings, L.M., 1946. A transmissible gastroenteritis in pigs. J.
Am. Vet. Med Assoc. 108, 257–259.
Furuuchi, S., Shimizu, M., Shimizu, Y., 1978. Field trials on transmissible
gastroenteritis live virus vaccine in newborn piglets. Natl. Inst. Anim. Health
Q (Tokyo) 18 (3–4), 135–142.
Godet, M., Grosclaude, J., Delmas, B., Laude, H., 1994. Major receptor-binding
and neutralization determinants are located within the same domain of the
transmissible gastroenteritis virus (coronavirus) spike protein. J. Virol. 68
(12), 8008–8016.
Goloboff, P., Farris, S., Nixon, K., 2005. TNT: Tree Analysis Using New
Technologies. Software package distributed by the authors and available at:
http://www.zmuc.dk/public/phylogeny/TNT.
Haelterman, E.O., 1964. Epidemiological studies of transmissible gastroenteritis
of swine. Proc. U. S. Livestock San Assoc. 68, 305–314.
Halbur, P.G., Paul, P.S., Vaughn, E.M., Andrews, J.J., 1993. Experimental
reproduction of pneumonia in gnotobiotic pigs with porcine respiratory
coronavirus isolate AR310. J. Vet. Diagn. Invest. 5 (2), 184–188.
Hampton, T., 2005. Bats may be SARS reservoir. JAMA 294 (18), 2291.
Harada, K., Furuuchi, S., Kumagai, T., Sasahara, J., 1969. Pathogenicity,
immunogenicity and distribution of transmissible gastroenteritis virus in
pigs. Natl. Inst. Anim. Health Q (Tokyo) 9 (4), 185–192.
Hasoksuz, M., Hoet, A.E., Loerch, S.C., Wittum, T.E., Nielsen, P.R., Saif, L.J.,
2002. Detection of respiratory and enteric shedding of bovine coronaviruses
in cattle in an Ohio feedlot. J. Vet. Diagn. Invest. 14 (4), 308–313.
Hill, H., Wood, B.J., et al., 1990. Porcine respiratory coronavirus isolated from
two US swine herds. Proceedings, 21st Annu. Meet Am. Assoc. Swine
Proct. , pp. 333–335.
Hodgson, T., Cavanagh, B.P., 2006. Neither the RNA nor the proteins of open
reading frames 3a and 3b of the coronavirus infectious bronchitis virus are
essential for replication. J. Virol. 80 (1), 296–305.
Izeta, A., Smerdou, C., Alonso, S., Penzes, Z., Mendez, A., Plana-Duran, J.,
Enjuanes, L., 1999. Replication and packaging of transmissible gastroen-
teritis coronavirus-derived synthetic minigenomes. J. Virol. 73 (2),
1535–1545.
Kemeny, L.J., Woods, R.D., 1977. Quantitative transmissible gastroenteritis
virus shedding patterns in lactating sows. Am. J. Vet. Res. 38 (3),
307–310.
Kim, L., Hayes, J., Lewis, P., Parwani, A.V., Chang, K.O., Saif, L.J., 2000.
Molecular characterization and pathogenesis of transmissible gastroenteritis
coronavirus (TGEV) and porcine respiratory coronavirus (PRCV) field
isolates co-circulating in a swine herd. Arch. Virol. 145 (6), 1133–1147.
434 X. Zhang et al. / Virology 358 (2007) 424–435Kwon, H.M., Saif, L.J., Jackwood, D.J., 1998. Field isolates of transmissible
gastroenteritis virus differ at the molecular level from the Miller and Purdue
virulent and attenuated strains and from porcine respiratory coronaviruses.
J. Vet. Med. Sci. 60 (5), 589–597.
Lai, M.M., Cavanagh, D., 1997. The molecular biology of coronaviruses. Adv.
Virus Res. 48, 1–100.
Lau, S.K., Woo, P.C., Li, K.S., Huang, Y., Tsoi, H.W., Wong, B.H., Wong, S.S.,
Leung, S.Y., Chan, K.H., Yuen, K.Y., 2005. Severe acute respiratory
syndrome coronavirus-like virus in Chinese horseshoe bats. Proc. Natl.
Acad. Sci. U.S.A. 102 (39), 14040–14045.
Laude, H., Gelfi, J., Lavenant, L., Charley, B., 1992. Single amino acid changes
in the viral glycoprotein M affect induction of alpha interferon by the
coronavirus transmissible gastroenteritis virus. J. Virol. 66 (2), 743–749.
Li, W., Shi, Z., Yu, M., Ren, W., Smith, C., Epstein, J.H., Wang, H., Crameri, G.,
Hu, Z., Zhang, H., Zhang, J., McEachern, J., Field, H., Daszak, P., Eaton,
B.T., Zhang, S., Wang, L.F., 2005. Bats are natural reservoirs of SARS-
like coronaviruses. Science 310 (5748), 676–679.
Marra, M.A., Jones, S.J., Astell, C.R., Holt, R.A., Brooks-Wilson, A.,
Butterfield, Y.S., Khattra, J., Asano, J.K., Barber, S.A., Chan, S.Y., Cloutier,
A., Coughlin, S.M., Freeman, D., Girn, N., Griffith, O.L., Leach, S.R.,
Mayo, M., McDonald, H., Montgomery, S.B., Pandoh, P.K., Petrescu, A.S.,
Robertson, A.G., Schein, J.E., Siddiqui, A., Smailus, D.E., Stott, J.M., Yang,
G.S., Plummer, F., Andonov, A., Artsob, H., Bastien, N., Bernard, K.,
Booth, T.F., Bowness, D., Czub, M., Drebot, M., Fernando, L., Flick, R.,
Garbutt, M., Gray, M., Grolla, A., Jones, S., Feldmann, H., Meyers, A.,
Kabani, A., Li, Y., Normand, S., Stroher, U., Tipples, G.A., Tyler, S., Vogrig,
R., Ward, D., Watson, B., Brunham, R.C., Krajden, M., Petric, M.,
Skowronski, D.M., Upton, C., Roper, R.L., 2003. The genome sequence of
the SARS-associated coronavirus. Science 300 (5624), 1399–1404.
Martin Alonso, J.M., Balbin, M., Garwes, D.J., Enjuanes, L., Gascon, S., Parra,
F., 1992. Antigenic structure of transmissible gastroenteritis virus
nucleoprotein. Virology 188 (1), 168–174.
McGoldrick, A., Lowings, J.P., Paton, D.J., 1999. Characterisation of a recent
virulent transmissible gastroenteritis virus from Britain with a deleted
ORF3a. Arch. Virol. 144 (4), 763–770.
Normile, D., 2005. Virology. Researchers tie deadly SARS virus to bats. Science
309 (5744), 2154–2155.
Ortego, J., Sola, I., Almazan, F., Ceriani, J.E., Riquelme, C., Balasch, M., Plana,
J., Enjuanes, L., 2003. Transmissible gastroenteritis coronavirus gene 7 is
not essential but influences in vivo virus replication and virulence. Virology
308 (1), 13–22.
Page, K.W., Mawditt, K.L., Britton, P., 1991. Sequence comparison of the 5′ end
of mRNA 3 from transmissible gastroenteritis virus and porcine respiratory
coronavirus. J. Gen. Virol. 72, 579–587.
Paton, D., Ibata, G., Sands, J., McGoldrick, A., 1997. Detection of transmissible
gastroenteritis virus by RT-PCR and differentiation from porcine respiratory
coronavirus. J. Virol. Methods 66 (2), 303–309.
Paul, P.S., Vaughn, E.M., Halbur, P.G., 1997. Pathogenicity and sequence
analysis studies suggest potential role of gene 3 in virulence of swine enteric
and respiratory coronaviruses. Adv. Exp. Med. Biol. 412, 317–321.
Pensaert, M., Callebaut, P., Vergote, J., 1986. Isolation of a porcine respiratory,
non-enteric coronavirus related to transmissible gastroenteritis. Vet. Q 8 (3),
257–261.
Penzes, Z., Gonzalez, J.M., Calvo, E., Izeta, A., Smerdou, C., Mendez, A.,
Sanchez, C.M., Sola, I., Almazan, F., Enjuanes, L., 2001. Complete genome
sequence of transmissible gastroenteritis coronavirus PUR46-MAD clone
and evolution of the Purdue virus cluster. Virus Genes 23 (1), 105–118.
Pritchard, G.C., 1987. Transmissible gastroenteritis in endemically infected
breeding herds of pigs in East Anglia, 1981–85. Vet. Rec. 120 (10),
226–230.
Rasschaert, D., Laude, H., 1987. The predicted primary structure of the
peplomer protein E2 of the porcine coronavirus transmissible gastroenteritis
virus. J. Gen. Virol. 68, 1883–1890.
Rasschaert, D., Gelfi, J., Laude, H., 1987. Enteric coronavirus TGEV: partial
sequence of the genomic RNA, its organization and expression. Biochimie
69 (6–7), 591–600.
Rota, P.A., Oberste, M.S., Monroe, S.S., Nix, W.A., Campagnoli, R., Icenogle,
J.P., Penaranda, S., Bankamp, B., Maher, K., Chen, M.H., Tong, S., Tamin,A., Lowe, L., Frace, M., DeRisi, J.L., Chen, Q., Wang, D., Erdman, D.D.,
Peret, T.C., Burns, C., Ksiazek, T.G., Rollin, P.E., Sanchez, A., Liffick, S.,
Holloway, B., Limor, J., McCaustland, K., Olsen-Rasmussen, M., Fouchier,
R., Gunther, S., Osterhaus, A.D., Drosten, C., Pallansch, M.A., Anderson,
L.J., Bellini, W.J., 2003. Characterization of a novel coronavirus associated
with severe acute respiratory syndrome. Science 300 (5624), 1394–1399.
Saif, L.J., 2004. Animal coronaviruses: what can they teach us about the severe
acute respiratory syndrome? Rev. Sci. Tech. 23 (2), 643–660.
Saif, L.J., 2005. Comparative biology of animal coronaviruses: lessons for
SARS. In: Peiris, M., Anderson, L.J., Osterhaus, A.D.M.E., Klaus Stohr,
K.Y. (Eds.), Severe Acute Respiratory Syndrome. Blackwell Pub, Oxford,
UK, pp. 84–99.
Saif, L.J., Sestak, K., 2006. Transmissible gastroenteritis virus and porcine
respiratory coronavirus, In: Zimmerman, J.J., et al. (Ed.), Diseases of Swine,
9th ed. Iowa State University Press, Ames, Iowa, pp. 489–516.
Sanchez, C.M., Jimenez, G., Laviada, M.D., Correa, I., Sune, C., Bullido, M.,
Gebauer, F., Smerdou, C., Callebaut, P., Escribano, J.M., et al., 1990.
Antigenic homology among coronaviruses related to transmissible gastro-
enteritis virus. Virology 174 (2), 410–417.
Sanchez, C.M., Gebauer, F., Sune, C., Mendez, A., Dopazo, J., Enjuanes, L.,
1992. Genetic evolution and tropism of transmissible gastroenteritis
coronaviruses. Virology 190 (1), 92–105.
Sanchez, C.M., Izeta, A., Sanchez-Morgado, J.M., Alonso, S., Sola, I., Balasch,
M., Plana-Duran, J., Enjuanes, L., 1999. Targeted recombination demon-
strates that the spike gene of transmissible gastroenteritis coronavirus is a
determinant of its enteric tropism and virulence. J. Virol. 73 (9), 7607–7618.
Sawicki, S.G., Sawicki, D.L., 1990. Coronavirus transcription: subgenomic
mouse hepatitis virus replicative intermediates function in RNA synthesis.
J. Virol. 64 (3), 1050–1056.
Shen, S., Wen, Z.L., Liu, D.X., 2003. Emergence of a coronavirus infectious
bronchitis virus mutant with a truncated 3b gene: functional characterization
of the 3b protein in pathogenesis and replication. Virology 311 (1),
16–27.
Simkins, R.A., Saif, L.J., Weilnau, P.A., 1989. Epitope mapping and the
detection of transmissible gastroenteritis viral proteins in cell culture using
biotinylated monoclonal antibodies in a fixed-cell ELISA. Arch. Virol. 107
(3–4), 179–190.
Simkins, R.A., Weilnau, P.A., Bias, J., Saif, L.J., 1992. Antigenic variation
among transmissible gastroenteritis virus (TGEV) and porcine respiratory
coronavirus strains detected with monoclonal antibodies to the S protein of
TGEV. Am. J. Vet. Res. 53 (7), 1253–1258.
Simkins, R.A., Weilnau, P.A., Van Cott, J., Brim, T.A., Saif, L.J., 1993.
Competition ELISA, using monoclonal antibodies to the transmissible
gastroenteritis virus (TGEV) S protein, for serologic differentiation of pigs
infected with TGEVor porcine respiratory coronavirus. Am. J. Vet. Res. 54
(2), 254–259.
Sola, I., Alonso, S., Zuniga, S., Balasch, M., Plana-Duran, J., Enjuanes, L.,
2003. Engineering the transmissible gastroenteritis virus genome as an
expression vector inducing lactogenic immunity. J. Virol. 77 (7),
4357–4369.
Sune, C., Jimenez, G., Correa, I., Bullido, M.J., Gebauer, F., Smerdou, C.,
Enjuanes, L., 1990. Mechanisms of transmissible gastroenteritis coronavirus
neutralization. Virology 177 (2), 559–569.
Underdahl, N.R., Mebus, C.A., Torres-Medina, A., 1975. Recovery of
transmissible gastroenteritis virus from chronically infected experimental
pigs. Am. J. Vet. Res. 36 (10), 1473–1476.
VanCott, J.L., Brim, T.A., Simkins, R.A., Saif, L.J., 1993. Isotype-specific
antibody-secreting cells to transmissible gastroenteritis virus and porcine
respiratory coronavirus in gut- and bronchus-associated lymphoid tissues of
suckling pigs. J. Immunol. 150 (9), 3990–4000.
Vaughn, E.M., Halbur, P.G., Paul, P.S., 1994. Three new isolates of porcine
respiratory coronavirus with various pathogenicities and spike (S) gene
deletions. J. Clin. Microbiol. 32 (7), 1809–1812.
Welch, S.K., Saif, L.J., 1988. Monoclonal antibodies to a virulent strain of
transmissible gastroenteritis virus: comparison of reactivity with virulent and
attenuated virus. Arch. Virol. 101 (3–4), 221–235.
Wesley, R.D., Cheung, A.K., Michael, D.D., Woods, R.D., 1989. Nucleotide
sequence of coronavirus TGEV genomic RNA: evidence for 3 mRNA
435X. Zhang et al. / Virology 358 (2007) 424–435species between the peplomer and matrix protein genes. Virus Res. 13 (2),
87–100.
Wesley, R.D., Woods, R.D., Cheung, A.K., 1990a. Genetic basis for the
pathogenesis of transmissible gastroenteritis virus. J. Virol. 64 (10),
4761–4766.
Wesley, R.D., Woods, R.D., Hill, H.T., Biwer, J.D., 1990b. Evidence for
a porcine respiratory coronavirus, antigenically similar to transmissible
gastroenteritis virus, in the United States. J. Vet. Diagn. Invest. 2 (4),
312–317.
Wesley, R.D., Woods, R.D., Cheung, A.K., 1991. Genetic analysis of porcine
respiratory coronavirus, an attenuated variant of transmissible gastroenteritis
virus. J. Virol. 65 (6), 3369–3373.Wood, E.N., Pritchard, G.C., Gibson, E.A., 1981. Transmissible gastroenteritis
of pigs. Vet. Rec. 108 (2), 41.
Woods, R.D., 1976. Leukocyte-aggregation assay for transmissible gastroen-
teritis of swine. Am. J. Vet. Res. 37 (12), 1405–1408.
Woods, R.D., 1979. Humoral and cellular responses in swine exposed to
transmissible gastroenteritis virus. Am. J. Vet. Res. 40 (1), 108–110.
Woods, R.D., Wesley, R.D., 1986. Immune response in sows given transmis-
sible gastroenteritis virus or canine coronavirus. Am. J. Vet. Res. 47 (6),
1239–1242.
Yoo, D., Deregt, D., 2001. A single amino acid change within antigenic domain
II of the spike protein of bovine coronavirus confers resistance to virus
neutralization. Clin. Diagn. Lab. Immunol. 8 (2), 297–302.
